MarketCap
Facebook
X
Telegram
Country |
 USA |
IPO year |
- |
Industry |
Biotechnology |
Stock Exchange |
NYSE AMERICAN |
Shares |
20.2 M |
Market Cap[1] |
$ 30.5 M |
EBITDA (LTM) |
$ -9.58 M |
P/E (LTM) |
-2.34375 |
P/S (LTM) |
- |
EPS (LTM) |
-0.64 |
Other stocks of industry "Biotechnology"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
 |
Omeros Corporation
OMER
|
$ 16.26 | -1.75 % | $ 1.03 B | Nasdaq Global Select Market | USA |
 |
Xenetic Biosciences
XBIO
|
$ 2.02 | 1.0 % | $ 3.44 M | Nasdaq Capital Market | USA |
 |
XBiotech
XBIT
|
$ 1.99 | -1.49 % | $ 60.7 M | Nasdaq Global Select Market | USA |
 |
ORIC Pharmaceuticals
ORIC
|
$ 13.85 | 0.51 % | $ 1.22 B | Nasdaq Global Select Market | USA |
 |
Aligos Therapeutics
ALGS
|
$ 4.96 | -1.39 % | $ 49 M | Nasdaq Global Select Market | USA |
 |
Alkermes plc
ALKS
|
$ 43.48 | -1.43 % | $ 7.16 B | Nasdaq Global Select Market |  Irlanda |
 |
Jazz Pharmaceuticals plc
JAZZ
|
$ 211.97 | -0.84 % | $ 12.9 B | Nasdaq Global Select Market | Irlanda |
 |
Xenon Pharmaceuticals
XENE
|
$ 35.95 | -0.88 % | $ 2.85 B | Nasdaq Global Select Market |  Canada |
 |
Xeris Pharmaceuticals
XERS
|
$ 10.79 | -3.1 % | $ 1.73 B | Nasdaq Global Select Market | USA |
 |
Phio Pharmaceuticals Corp.
PHIO
|
$ 0.89 | 0.31 % | $ 5.33 M | Nasdaq Capital Market | USA |
 |
Kymera Therapeutics
KYMR
|
$ 112.63 | -0.73 % | $ 9.52 B | Nasdaq Global Market | USA |
 |
Praxis Precision Medicines
PRAX
|
$ 256.47 | -3.03 % | $ 5.77 B | Nasdaq Global Select Market,SPB | USA |
 |
ProQR Therapeutics N.V.
PRQR
|
$ 1.37 | -0.72 % | $ 144 M | Nasdaq Global Market |  Niderland |
 |
PTC Therapeutics
PTCT
|
$ 62.62 | -0.48 % | $ 4.98 B | Nasdaq Global Select Market,SPB | USA |
 |
Arcus Biosciences
RCUS
|
$ 19.1 | -19.58 % | $ 2.05 B | NYSE,SPB | USA |
|
Larimar Therapeutics
LRMR
|
$ 2.42 | -0.82 % | $ 201 M | Nasdaq Global Market | USA |
 |
Regeneron Pharmaceuticals
REGN
|
$ 805.67 | -0.22 % | $ 84.3 B | Nasdaq Global Select Market,SPB | USA |
 |
X4 Pharmaceuticals
XFOR
|
$ 3.01 | -0.33 % | $ 127 M | Nasdaq Capital Market | USA |
 |
Rafael Holdings
RFL
|
$ 1.3 | 0.78 % | $ 38.2 M | NYSE | USA |
 |
REGENXBIO
RGNX
|
$ 7.17 | -3.11 % | $ 370 M | Nasdaq Global Select Market,SPB | USA |
 |
Royalty Pharma plc
RPRX
|
$ 62.15 | -0.16 % | $ 26.7 B | Nasdaq Global Select Market | USA |
 |
Seer
SEER
|
$ 2.03 | 2.53 % | $ 112 M | Nasdaq Global Select Market | USA |
 |
PDS Biotechnology Corporation
PDSB
|
$ 1.24 | 29.1 % | $ 57.5 M | Nasdaq Capital Market | USA |
 |
Zymeworks
ZYME
|
$ 28.12 | 4.48 % | $ 1.45 B | NYSE | Canada |
 |
SIGA Technologies
SIGA
|
$ 3.12 | -0.95 % | $ 223 M | Nasdaq Global Select Market | USA |
 |
Nanobiotix S.A.
NBTX
|
$ 25.83 | 7.0 % | $ 1.24 T | Nasdaq Global Select Market |  France |
 |
22nd Century Group
XXII
|
$ 0.27 | 2.13 % | $ 49.7 K | NYSE American | USA |
 |
Syndax Pharmaceuticals
SNDX
|
$ 13.15 | -0.75 % | $ 1.14 B | Nasdaq Global Select Market | USA |
 |
Soligenix
SNGX
|
$ 0.35 | -1.27 % | $ 1.82 M | Nasdaq Capital Market | USA |
 |
Intellia Therapeutics
NTLA
|
$ 11.65 | -1.6 % | $ 1.26 B | Nasdaq Global Market,SPB | USA |
|
Nuvation Bio
NUVB
|
$ 4.85 | 1.89 % | $ 1.66 B | NYSE | USA |
 |
Sarepta Therapeutics
SRPT
|
$ 18.56 | -3.18 % | $ 1.86 B | Nasdaq Global Select Market,SPB | USA |
 |
Processa Pharmaceuticals
PCSA
|
$ 1.76 | 1.73 % | $ 2.3 M | Nasdaq Global Select Market | USA |
 |
RedHill Biopharma Ltd.
RDHL
|
$ 0.46 | -10.31 % | $ 5.67 B | Nasdaq Global Market |  Israel |
 |
SELLAS Life Sciences Group
SLS
|
$ 12.14 | 1.34 % | $ 1.32 B | Nasdaq Capital Market | USA |
|
Protara Therapeutics
TARA
|
$ 2.5 | -2.34 % | $ 107 M | Nasdaq Global Market | USA |
 |
Relay Therapeutics
RLAY
|
$ 18.41 | -0.22 % | $ 3.16 B | Nasdaq Global Market | USA |
 |
Pfizer
PFE
|
$ 29.85 | -0.95 % | $ 170 B | NYSE,SPB | USA |
 |
Supernus Pharmaceuticals
SUPN
|
$ 41.21 | -0.05 % | $ 2.33 B | Nasdaq Global Select Market,SPB | USA |
 |
Takeda Pharmaceutical Company Limited
TAK
|
$ 19.93 | -0.75 % | $ 31.5 B | NYSE |  Japan |
 |
Revolution Medicines
RVMD
|
$ 194.28 | -1.15 % | $ 36.9 B | Nasdaq Global Select Market | USA |
 |
Rhythm Pharmaceuticals
RYTM
|
$ 88.62 | -1.75 % | $ 5.76 B | Nasdaq Global Market,SPB | USA |
 |
Prelude Therapeutics Incorporated
PRLD
|
$ 3.65 | 3.4 % | $ 281 M | Nasdaq Global Select Market | USA |
 |
Sana Biotechnology
SANA
|
$ 2.35 | -0.42 % | $ 595 M | Nasdaq Global Select Market | USA |
 |
Zai Lab Limited
ZLAB
|
$ 24.2 | -3.51 % | $ 26.5 B | Nasdaq Global Select Market |  China |
 |
Pulmatrix
PULM
|
$ 1.57 | 9.79 % | $ 5.73 B | Nasdaq Global Select Market | USA |
 |
Zentalis Pharmaceuticals
ZNTL
|
$ 2.36 | -1.26 % | $ 170 M | Nasdaq Global Market | USA |
 |
Zoetis
ZTS
|
$ 79.62 | -0.52 % | $ 35.3 B | NYSE,SPB | USA |
 |
Ultragenyx Pharmaceutical
RARE
|
$ 15.92 | -0.62 % | $ 1.57 B | Nasdaq Global Select Market,SPB | USA |
 |
XTL Biopharmaceuticals Ltd.
XTLB
|
$ 1.87 | -3.61 % | $ 1.26 B | Nasdaq Capital Market | Israel |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.